Sterling
Novo Nordisk logo
Novo Nordisk
Roche logo
Roche

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Novo Nordisk 12.087, Roche 17.1305.

* Roche reports semi-annually. Values are evenly split across both quarters within each half.

Novo Nordisk vs Roche Net Worth and Market Cap

Novo Nordisk (NVO) and Roche (RHHBY) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $34.3B for Roche. Roche leads on revenue.

Novo Nordisk's gross margin is 78.2% versus 71.7% for Roche. Novo Nordisk's net margin is 26.7% versus 17.9% for Roche.

Key differences

  • Revenue growth on the same quarter a year earlier: Novo Nordisk +2.1% (Q2 2026), Roche -4.2% (Q4 2025).
  • Novo Nordisk keeps more of its revenue as operating profit: a 34.5% operating margin, against 23.2% at Roche.
  • Novo Nordisk's KPIs on Sterling include Next-Generation Obesity: CagriSema + Amycretin Readouts and 2030 Ambitions (Capital Markets Day, 21 Sep 2026).
  • Roche's KPIs on Sterling include Carmot Asset Pipeline: CT-388, CT-996, CT-868 Trial Readout Timeline and CT-868 (Acmopatide) Discontinuation.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Roche.
MetricNovo NordiskRoche
Market Cap--
Revenue$12.09B$34.26B
Cost of Revenue$2.63B$9.68B
Gross Profit$9.45B$24.58B
Operating Income$4.17B$7.96B
Net Income$3.23B$6.13B
R&D Expense$2.74B$7.48B
Earnings Per Share$0.73$0.95
Gross Margin78.2%71.7%
Operating Margin34.5%23.2%
Net Profit Margin26.7%17.9%
Free Cash Flow$6.53B$10.67B
Cumulative Free Cash Flow$107.39B$299.34B
Operating Cash Flow$8.50B$13.12B
Cash & Equivalents$6.85B$6.32B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites